Aquestive Therapeutics (AQST) Operating Income Growth (3y) (2020 - 2026)
Aquestive Therapeutics (AQST) Operating Income Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 273.62% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 3.84% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 4.63% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 31.70% |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 54.58% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 40.87% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -63.87% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 120.38% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -90.87% |
| 10 | Aquestive Therapeutics | 487.99 Mn | 377.25 Mn | 10.98 Mn | 2.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.99% |
| Dec 31, 2025 | -39.11% |
| Sep 30, 2025 | -9.04% |
| Jun 30, 2025 | 3.78% |
| Mar 31, 2025 | -25.75% |
| Dec 31, 2024 | -5.18% |
| Sep 30, 2024 | -1.33% |
| Jun 30, 2024 | 26.17% |
| Mar 31, 2024 | -1.66% |
| Dec 31, 2023 | 37.01% |
| Sep 30, 2023 | 44.33% |
| Jun 30, 2023 | -133.04% |
| Mar 31, 2023 | 30.74% |
| Dec 31, 2022 | -2.65% |
| Sep 30, 2022 | 6.99% |
| Jun 30, 2022 | 11.94% |
| Mar 31, 2022 | 9.35% |
| Dec 31, 2021 | 1.88% |
| Sep 30, 2021 | 4.70% |
| Jun 30, 2021 | 41.59% |